Multidisciplinary Training Program in Pediatric Lung Diseases

小儿肺部疾病多学科培训计划

基本信息

项目摘要

Project Summary The goals of the T32 Multidisciplinary Training Program in Pediatric Lung Diseases at Children’s Hospital of Philadelphia are: (1) To provide a mechanism for training by which postdoctoral fellows can pursue and develop successful academic careers in clinical, translational, or basic research, creating a diverse pipeline of investigators dedicated to improving child lung health; (2) To advance pediatric lung research through training physician scientists and PhD scientists in the areas of (a) genetic and rare lung diseases, including interstitial lung disease (ILD), cystic fibrosis (CF), bronchopulmonary dysplasia (BPD), and pulmonary vascular disease, (b) lung injury, repair, and development, (c) asthma, inflammation and the environment, and (d) respiratory physiology; and (3) To create a cohesive and collaborative environment among trainees and leading investigators that promotes learning and cooperation across a spectrum of patient-oriented and basic investigation, resulting in rigorous and high impact advances in respiratory health in children. The program is committed to equal opportunity for its faculty, staff, and students and does not discriminate on the basis of any legally protected characteristics. The proposed training program will provide 2-3 years of training in pediatric lung-related research at the postdoctoral level for qualified candidates with an MD, MD/PhD, or DO degree and 1-3 years of training for those with a PhD degree. We are requesting support for 4 post-doctoral fellows/year. This training program is the result of a robust collaboration between research faculty members at the Children’s Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania. These faculty offer mentored training in patient-oriented or basic research within the four thematic areas noted above. The mentor-mentee relationship between research preceptor and trainee will be central to the training experience, which will be supplemented by formal training in clinical and laboratory investigation, preparation of grant applications, participation in a responsible conduct of research curriculum and program-wide conferences, presentation of original research at national scientific meetings, and publication of original research in peer-reviewed journals. Drs. Lisa Young and Sharon McGrath-Morrow are the Program Directors and will have overall responsibility for coordination of the program, including its scientific, educational, and administrative aspects. To support excellence in the research training of this T32 program, the Program Directors will receive consultation from an Internal Steering Committee and an External Advisory Board. The Children’s Hospital of Philadelphia has one of the largest and strongest pediatric pulmonary fellowship programs in the country and is the oldest children’s hospital in the United States. The Program Directors have trained many leaders in the field for Pediatric Pulmonology and are uniquely positioned to facilitate success among postdoctoral trainees who will become physician scientists and researchers in pediatric lung-related research.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sharon Ann McGrath-Morrow其他文献

Sharon Ann McGrath-Morrow的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sharon Ann McGrath-Morrow', 18)}}的其他基金

Multidisciplinary Training Program in Pediatric Lung Diseases
小儿肺部疾病多学科培训计划
  • 批准号:
    10594441
  • 财政年份:
    2022
  • 资助金额:
    $ 40.94万
  • 项目类别:
Resolution of Diffuse Inflammatory Lung Injury in Neonatal Mice
新生小鼠弥漫性炎症性肺损伤的解决
  • 批准号:
    8680365
  • 财政年份:
    2013
  • 资助金额:
    $ 40.94万
  • 项目类别:
Resolution of Diffuse Inflammatory Lung Injury in Neonatal Mice
新生小鼠弥漫性炎症性肺损伤的解决
  • 批准号:
    9769845
  • 财政年份:
    2013
  • 资助金额:
    $ 40.94万
  • 项目类别:
Resolution of Diffuse Inflammatory Lung Injury in Neonatal Mice
新生小鼠弥漫性炎症性肺损伤的解决
  • 批准号:
    9613428
  • 财政年份:
    2013
  • 资助金额:
    $ 40.94万
  • 项目类别:
Resolution of Diffuse Inflammatory Lung Injury in Neonatal Mice
新生小鼠弥漫性炎症性肺损伤的解决
  • 批准号:
    8502861
  • 财政年份:
    2013
  • 资助金额:
    $ 40.94万
  • 项目类别:
Resolution of Diffuse Inflammatory Lung Injury in Neonatal Mice
新生小鼠弥漫性炎症性肺损伤的解决
  • 批准号:
    10226540
  • 财政年份:
    2013
  • 资助金额:
    $ 40.94万
  • 项目类别:
Resolution of Diffuse Inflammatory Lung Injury in Neonatal Mice
新生小鼠弥漫性炎症性肺损伤的解决
  • 批准号:
    10245317
  • 财政年份:
    2013
  • 资助金额:
    $ 40.94万
  • 项目类别:
NIGHTTIME HYPOXEMIA IN TEENAGERS WITH ATAXIA TELANGIECTASIA
毛细血管扩张性共济失调青少年的夜间低氧血症
  • 批准号:
    7604677
  • 财政年份:
    2006
  • 资助金额:
    $ 40.94万
  • 项目类别:
Multidisciplinary Training Program in Pediatric Pulmonary
小儿肺科多学科培训计划
  • 批准号:
    9068331
  • 财政年份:
    2003
  • 资助金额:
    $ 40.94万
  • 项目类别:
REGULATION OF GROWTH ARREST IN HYPEROXIC NEONATAL LUNG
高氧新生儿肺生长停滞的调节
  • 批准号:
    2027141
  • 财政年份:
    1997
  • 资助金额:
    $ 40.94万
  • 项目类别:

相似海外基金

Using base editing to investigate CFTR polymorphisms in lung diseases
使用碱基编辑研究肺部疾病中的 CFTR 多态性
  • 批准号:
    10833839
  • 财政年份:
    2023
  • 资助金额:
    $ 40.94万
  • 项目类别:
Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Lung Diseases
肺生物学和肺部疾病中的干细胞、细胞疗法和生物工程
  • 批准号:
    10753310
  • 财政年份:
    2023
  • 资助金额:
    $ 40.94万
  • 项目类别:
Bispecific immunotherapeutic delivery system for lung diseases
用于肺部疾病的双特异性免疫治疗递送系统
  • 批准号:
    10720773
  • 财政年份:
    2023
  • 资助金额:
    $ 40.94万
  • 项目类别:
Novel gene therapy platform for monogenetic lung diseases
单基因肺部疾病的新型基因治疗平台
  • 批准号:
    491900
  • 财政年份:
    2023
  • 资助金额:
    $ 40.94万
  • 项目类别:
    Operating Grants
Exploring and Establishing Endotyping Markers in Obstructive Lung Diseases
探索和建立阻塞性肺疾病的内型标记物
  • 批准号:
    23K15204
  • 财政年份:
    2023
  • 资助金额:
    $ 40.94万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Investigation of airway mucin expression in the distal airway and alveolar regions of interstitial lung diseases
间质性肺疾病远端气道和肺泡区气道粘蛋白表达的研究
  • 批准号:
    22K21371
  • 财政年份:
    2023
  • 资助金额:
    $ 40.94万
  • 项目类别:
    Fund for the Promotion of Joint International Research (Home-Returning Researcher Development Research)
Partnerships for Research in Implementation Science for Equity in Heart and Lung diseases training program (PRISE-HL T32)
心肺疾病公平实施科学研究伙伴关系培训计划 (PRISE-HL T32)
  • 批准号:
    10553831
  • 财政年份:
    2023
  • 资助金额:
    $ 40.94万
  • 项目类别:
Complement Pathway Activation in Idiopathic Pulmonary Fibrosis and other Progressive Fibrosing Interstitial Lung Diseases
特发性肺纤维化和其他进行性纤维化间质性肺疾病中的补体途径激活
  • 批准号:
    10590870
  • 财政年份:
    2023
  • 资助金额:
    $ 40.94万
  • 项目类别:
CMKLR1-Targeted Molecular Imaging of Inflammation as a Precision Medicine Tool in Acute Lung Injury and Fibrotic Lung Diseases
CMKLR1 靶向炎症分子成像作为急性肺损伤和纤维化肺疾病的精准医学工具
  • 批准号:
    10733483
  • 财政年份:
    2023
  • 资助金额:
    $ 40.94万
  • 项目类别:
Coarse-grained Simulation Study on Polynucleotide Delivery to Treat Lung Diseases
多核苷酸递送治疗肺部疾病的粗粒度模拟研究
  • 批准号:
    576036-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 40.94万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了